1.1 Buyer
Official name
:
SYKEHUSINNKJØP HF
Blood radiation IMTRA for Akershus University Hospital.
Immunoolgical and transfusion medical department (IMTRA) at Akershus University Hospital HF (Ahus) intends to enter into a contract with Norsk Labex AS for the delivery of radiating blood beams RS3400 6x1 litres. Immunoolgical and transfusion medical department (IMTRA) at Akershus University Hospital HF (Ahus) intends to enter into a contract …
CPV: 33150000 Apparatur för radioterapi, mekanoterapi, elektroterapi och sjukgymnastik
1. Buyer
2. Procedure
2.1 Procedure
Title
:
Blood radiation IMTRA for Akershus University Hospital.
Description
:
Immunoolgical and transfusion medical department (IMTRA) at Akershus University Hospital HF (Ahus) intends to enter into a contract with Norsk Labex AS for the delivery of radiating blood beams RS3400 6x1 litres.
Procedure identifier
:
a359bffe-c070-4698-8ff7-ef8e0d4ddf4a
Internal identifier
:
2025/48930
Type of procedure
:
Negotiated without prior call for competition
2.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33150000
Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices
2.1.2 Place of performance
Country subdivision (NUTS)
:
Akershus
(
NO084
)
Country
:
Norway
2.1.4 General information
Legal basis
:
Directive 2014/24/EU
Anskaffelsesforskriften
-
Immunoolgical and transfusion medical department (IMTRA) at Akershus University Hospital HF (Ahus) intends to enter into a contract with Norsk Labex AS for the delivery of radiating blood beams RS3400 6x1 litres.
5. Lot
5.1 Lot technical ID : LOT-0000
Title
:
Blood radiation IMTRA for Akershus University Hospital.
Description
:
Immunoolgical and transfusion medical department (IMTRA) at Akershus University Hospital HF (Ahus) intends to enter into a contract with Norsk Labex AS for the delivery of radiating blood beams RS3400 6x1 litres.
Internal identifier
:
2025/48930
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33150000
Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices
5.1.2 Place of performance
Country subdivision (NUTS)
:
Akershus
(
NO084
)
Country
:
Norway
Additional information
:
5.1.6 General information
The procurement is covered by the Government Procurement Agreement (GPA)
:
yes
5.1.16 Further information, mediation and review
Review organisation
:
Indre og Østre Finnmark tingrett
-
Organisation whose budget is used to pay for the contract
:
SYKEHUSINNKJØP HF
6. Results
Direct award
:
Justification for direct award
:
The contract can be provided only by a particular economic operator because of an
absence of competition for technical reasons
Other justification
:
On average Ahus transfunders approx. 50 units irradiated erythrocytes and approx. 50 units irradiated thrombocytes per month, total approx. 1,200 irradiated units per annum. We see that new treatment methods for several diagnoses lead to an increasing need for irradiated cellular blood components, where the need for such transfusions is 24/7. Several of the patients should have delivered several units of both erythrocytes and thrombocytes in the same order. In order to cover the current need and ensure future needs, it is necessary that the instrument has the capacity to irradiate multiple units of both erythrocytes and thrombocytes simultaneously. All blood banks in Norway are currently working on contingency plans for all areas of operations. Particularly vulnerable is the demise of technical infrastructure such as ICT, electricity and water. In order to ensure that the instrument can function on emergency/back-up power and interruption power supply (UPS), it is necessary that the instrument can use 1 fas, which is available in the room where the new apparatus shall be placed and have internal cooling without a need for water connection. Ahus, as one of Norway's largest hospitals, needs the new instrument to have the shortest possible delivery time so that the department can, as soon as possible, have a predictable, safe and well-functioning offer on irradiation of cellular blood components to vulnerable patient groups. Based on this, the Contracting Authority considers that the procurement could be exempted from the terms in the Regulations 12 August 2016 no. 974 on public procurements (the procurement regulations – FOA) § 13-4, letter b, point 2.
6.1 Result lot ldentifier : LOT-0000
6.1.2 Information about winners
Winner
:
Official name
:
Norsk Labex AS
Tender
:
Tender identifier
:
Tilbud
Identifier of lot or group of lots
:
LOT-0000
Contract information
:
Identifier of the contract
:
Blodbestråler IMTRA til Akershus Universitetssykehus HF
8. Organisations
8.1 ORG-0001
Official name
:
SYKEHUSINNKJØP HF
Registration number
:
916879067
Postal address
:
Postboks 40
Town
:
VADSØ
Postcode
:
9811
Country subdivision (NUTS)
:
Akershus
(
NO084
)
Country
:
Norway
Contact point
:
Postmottak Sykehusinnkjøp
Telephone
:
+47 78950700
Roles of this organisation
:
Buyer
Organisation whose budget is used to pay for the contract
8.1 ORG-0002
Official name
:
Indre og Østre Finnmark tingrett
Registration number
:
926722840
Town
:
Vadsø
Postcode
:
9800
Country subdivision (NUTS)
:
Finnmark/Finnmárku/Finmarkku
(
NO073
)
Country
:
Norway
Roles of this organisation
:
Review organisation
8.1 ORG-0003
Official name
:
Norsk Labex AS
Town
:
Høvik
Postcode
:
1363
Country subdivision (NUTS)
:
Akershus
(
NO084
)
Country
:
Norway
Roles of this organisation
:
Tenderer
Winner of these lots
:
LOT-0000
Notice information
Notice identifier/version
:
b7c4aa20-90a2-4ec9-8668-e4527b02aa26
-
01
Form type
:
Direct award preannouncement
Notice type
:
Voluntary ex-ante transparency notice
Notice dispatch date
:
07/05/2025
10:55 +00:00
Notice dispatch date (eSender)
:
07/05/2025
11:06 +00:00
Languages in which this notice is officially available
:
English
Notice publication number
:
00295839-2025
OJ S issue number
:
89/2025
Publication date
:
08/05/2025